These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28069603)

  • 21. Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?
    Bridoux F; Desport E; Frémeaux-Bacchi V; Chong CF; Gombert JM; Lacombe C; Quellard N; Touchard G
    Clin J Am Soc Nephrol; 2011 Sep; 6(9):2165-74. PubMed ID: 21784830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
    Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
    Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C3 glomerulonephritis associated with monoclonal gammopathy: a case series.
    Zand L; Kattah A; Fervenza FC; Smith RJ; Nasr SH; Zhang Y; Vrana JA; Leung N; Cornell LD; Sethi S
    Am J Kidney Dis; 2013 Sep; 62(3):506-14. PubMed ID: 23623956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C3 glomerulonephritis associated with monoclonal gammopathy: a retrospective case series study from a single institute in China.
    Zhang X; Yu XJ; Li DY; Wang SX; Zhou FD; Zhao MH
    Ren Fail; 2021 Dec; 43(1):1437-1445. PubMed ID: 34658305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 78-Year-Old Man with Chronic Kidney Disease and Monoclonal Gammopathy Who Developed Post-Transplant C3 Glomerulopathy - Recurrence or De Novo? A Case Report and Literature Review.
    Ruiz-Fuentes MC; Caba-Molina M; Polo-Moyano A; Palomares-Bayo M; Galindo-Sacristan P; De Gracia-Guindo C
    Am J Case Rep; 2023 Jun; 24():e939726. PubMed ID: 37329130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
    Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
    BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal gammopathy-associated proliferative glomerulonephritis.
    Sethi S; Rajkumar SV
    Mayo Clin Proc; 2013 Nov; 88(11):1284-93. PubMed ID: 24182705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study.
    Joly F; Cohen C; Javaugue V; Bender S; Belmouaz M; Arnulf B; Knebelmann B; Nouvier M; Audard V; Provot F; Gnemmi V; Nochy D; Goujon JM; Jaccard A; Touchard G; Fermand JP; Sirac C; Bridoux F
    Blood; 2019 Feb; 133(6):576-587. PubMed ID: 30578255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist.
    Sicard A; Karras A; Goujon JM; Sirac C; Bender S; Labatut D; Callard P; Sarkozy C; Essig M; Vanhille P; Provot F; Nony A; Nochy D; Ronco P; Bridoux F; Touchard G
    Nephrol Dial Transplant; 2014 Oct; 29(10):1894-902. PubMed ID: 24619059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysproteinemias and Glomerular Disease.
    Leung N; Drosou ME; Nasr SH
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):128-139. PubMed ID: 29114004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daratumumab in the treatment of C3 glomerulopathy with monoclonal gammopathy: a case report and literature review.
    Esposito P; Picciotto D; Costigliolo F; Russo E; Macciò L; Cenacchi G; Cagnetta A; Cea M; Lemoli RM; Viazzi F
    Front Med (Lausanne); 2023; 10():1266172. PubMed ID: 37724175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of monoclonal gammopathy of renal significance.
    Bridoux F; Leung N; Hutchison CA; Touchard G; Sethi S; Fermand JP; Picken MM; Herrera GA; Kastritis E; Merlini G; Roussel M; Fervenza FC; Dispenzieri A; Kyle RA; Nasr SH;
    Kidney Int; 2015 Apr; 87(4):698-711. PubMed ID: 25607108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal pathologic spectrum and clinical outcome of monoclonal gammopathy of renal significance: A large retrospective case series study from a single institute in China.
    Yu XJ; Zhang X; Li DY; Wang SX; Zhou FD; Zhao MH
    Nephrology (Carlton); 2020 Mar; 25(3):202-211. PubMed ID: 31301197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Durable remission of C3 glomerulonephritis with mycophenolate mofetil.
    Lioufas N; Finlay M; Barbour T
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():36-39. PubMed ID: 28176473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.
    Leung N; Bridoux F; Hutchison CA; Nasr SH; Cockwell P; Fermand JP; Dispenzieri A; Song KW; Kyle RA;
    Blood; 2012 Nov; 120(22):4292-5. PubMed ID: 23047823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Monoclonal gammopathy of renal significance and membranoproliferative glomerulonephritis: a complex relationship with promising therapeutic opportunities].
    Manes M; Radin E; Pellu' V; Molino A A; Gabrielli D; Parodi E; Caputo D; Paternoster G; Barreca A; Pagliaro M; Quattrocchio G; Roccatello D
    G Ital Nefrol; 2019 Jul; 36(4):. PubMed ID: 31373468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generalized cutis laxa and fibrillar glomerulopathy resulting from IgG Deposition in IgG-lambda Monoclonal Gammopathy: pulmonary hemorrhage during stem cell mobilization and complete hematological response with bortezomib and dexamethasone therapy.
    Fernández de Larrea C; Rovira M; Mascaró JM; Torras A; Solé M; Lloreta J; Serra N; Cibeira MT; Bladé J
    Eur J Haematol; 2009 Feb; 82(2):154-8. PubMed ID: 19018863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results from a nationwide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathy.
    Chauvet S; Hauer JJ; Petitprez F; Rabant M; Martins PV; Baudouin V; Delmas Y; Jourde-Chiche N; Cez A; Ribes D; Cloarec S; Servais A; Zaidan M; Daugas E; Delahousse M; Wynckel A; Ryckewaert A; Sellier-Leclerc AL; Boyer O; Thervet E; Karras A; Smith RJH; Frémeaux-Bacchi V
    Kidney Int; 2022 Oct; 102(4):904-916. PubMed ID: 35752323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits.
    Zand L; Rajkumar SV; Leung N; Sethi S; El Ters M; Fervenza FC
    J Am Soc Nephrol; 2021 May; 32(5):1163-1173. PubMed ID: 33685975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal gammopathy: significance and possible causality in renal disease.
    Paueksakon P; Revelo MP; Horn RG; Shappell S; Fogo AB
    Am J Kidney Dis; 2003 Jul; 42(1):87-95. PubMed ID: 12830460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.